Read + Share
Amedeo Smart
Independent Medical Education
Vazquez C, Gonzalez ML, Ferraris A, Bandi JC, et al. Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia. PLoS One 2020;15:e0228486.PMID: 32032395
Email
LinkedIn
Facebook
Twitter
Privacy Policy